PROFIT 500

PROFIT 500 National Sponsors

#183

BioSyent Inc.

Snapshot

Licenses prescription drugs and markets them to wholesalers for sale to pharmacies or hospitals. A key growth driver is FeraMAX, an oral iron supplement that lacks the often unpleasant side effects of rival products.

Company Profile

Founded: 1992 Chief Executive(s): Rene Goehrum Stock Ticker: TSXV: RX
Website: www.biosyent.com Head Office: Toronto  

Company Financials

Growth 2007-12 (%): 355 Revenue 2012: 5,024,154 Reporting $: CAD
Exports as % of Sales: 2 Employees 2012: 18 Employees 2007: 7